The DOI matches its Crossref record; 27 of the 28 references it cites were found in a registry or an index.
Temporal Relations of Atrial Fibrillation and Congestive Heart Failure and Their Joint Influence on Mortality: The Framingham Heart Study
Abstract
Background— Atrial fibrillation (AF) and congestive heart failure (CHF) frequently occur together, but there is limited information regarding their temporal relations and the combined influence of these conditions on mortality. Methods and Results— We studied participants in the Framingham Study with new-onset AF or CHF. Multivariable Cox proportional hazards models with time-dependent variables were used to evaluate whether mortality after AF or CHF was affected by the occurrence and timing of the other condition. Hazard ratios (HRs) were adjusted for time period and cardiovascular risk factors. During the study period, 1470 participants developed AF, CHF, or both. Among 382 individuals with both conditions, 38% had AF first, 41% had CHF first, and 21% had both diagnosed on the same day. The incidence of CHF among AF subjects was 33 per 1000 person-years, and the incidence of AF among CHF subjects was 54 per 1000 person-years. In AF subjects, the subsequent development of CHF was associated with increased mortality (men: HR 2.7; 95% CI, 1.9 to 3.7; women: HR 3.1; 95% CI, 2.2 to 4.2). Similarly, in CHF subjects, later development of AF was associated with increased mortality (men: HR 1.6; 95% CI, 1.2 to 2.1; women: HR 2.7, 95% CI, 2.0 to 3.6). Preexisting CHF adversely affected survival in individuals with AF, but preexisting AF was not associated with adverse survival in those with CHF. Conclusions— Individuals with AF or CHF who subsequently develop the other condition have a poor prognosis. Additional studies addressing the pathogenesis, prevention, and optimal management of the joint occurrence of AF and CHF appear warranted.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In adjusted models, AF is associated with increased morbidity, especially stroke and heart failure, as well as increased mortality.2–5”
From Worldwide Epidemiology of Atrial Fibrillation: A Global Burden of Disease 2010 Study (2014) · cites this paper as [5]
In the citing paper
“The plasma concentrations of the inflammatory marker C-reactive protein143 and of fibroblast growth factor-23144 have been found to be higher in women than in men in epidemiological studies.”
From Atrial fibrillation in women: epidemiology, pathophysiology, presentation, and prognosis (2016) · cites this paper as [143]
Citations
Cites
Impact of Atrial Fibrillation on the Risk of Death: The Framingham Heart Study
Benjamin, E. J., Wolf, P. A., D’Agostino, R. B., Silbershatz, H., Kannel, W. B., & Levy, D. (1998) · Circulation · doi:10.1161/01.cir.98.10.946 · Cited by 4,575
Self-citationA comparison of rate control and rhythm control in patients with atrial fibrillation
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa021328 · Cited by 4,405
Benjamin, E. J. (1994) · JAMA · doi:10.1001/jama.1994.03510350050036 · Cited by 2,613
Self-citationLong-term trends in the incidence of and survival with heart failure
Levy, D., Kenchaiah, S., Larson, M. G., Benjamin, E. J., Kupka, M. J., Ho, K. K. L., Murabito, J. M., & Vasan, R. S. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020265 · Cited by 2,152
Self-citationEpidemiological approaches to heart disease: the Framingham study
Dawber, T. R., Meadors, G. F., & Moore, F. E. (1951) · American Journal of Public Health and the Nations Health · doi:10.2105/ajph.41.3.279 · Cited by 2,148
AN INVESTIGATION OF CORONARY HEART DISEASE IN FAMILIES
Kannel, W. B., Feinleib, M., McNAMARA, P. M., Garrison, R. J., & Castelli, W. P. (1979) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112813 · Cited by 1,639
Self-citationCardiovascular Medicine at the Turn of the Millennium: Triumphs, Concerns, and Opportunities
Braunwald, E. (1997) · New England Journal of Medicine · doi:10.1056/nejm199711063371906 · Cited by 1,426
Promotion of Atrial Fibrillation by Heart Failure in Dogs
Li, D., Fareh, S., Leung, T. K., & Nattel, S. (1999) · Circulation · doi:10.1161/01.cir.100.1.87 · Cited by 1,343
Congestive Heart Failure in the Community
Senni, M., Tribouilloy, C. M., Rodeheffer, R. J., Jacobsen, S. J., Evans, J. M., Bailey, K. R., & Redfield, M. M. (1998) · Circulation · doi:10.1161/01.cir.98.21.2282 · Cited by 1,088
Dofetilide in Patients with Congestive Heart Failure and Left Ventricular Dysfunction
Torp-Pedersen, C. T., Møller, M., Bloch-Thomsen, P.-E., Køber, L., Sandøe, E., Egstrup, K., Agner, E., Carlsen, J. E., Videbæk, J., Marchant, B., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909163411201 · Cited by 1,012
Cited by
Sorted by citations
Items 901–1,000 of 1,000
Ming, J., Wei, Y., Sun, H., Wong, G., Yang, G., Pong, R., & Chen, Y. (2019) · Value in Health · doi:10.1016/j.jval.2019.02.001 · Cited by 14
Bhat, A., Gan, G. C. H., Chen, H. H. L., Khanna, S., Nawaz, S., Nunes, M. C. P., Dobbins, T., MacIntyre, C. R., & Tan, T. C. (2021) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2021.06.015 · Cited by 15
Graff, S., Prior, A., Fenger‐Grøn, M., Christensen, B. M., Glümer, C., Larsen, F. B., & Vestergaard, M. (2017) · American Heart Journal · doi:10.1016/j.ahj.2017.03.002 · Cited by 15
Ramaswamy, K. (2003) · Cardiac Electrophysiology Review · doi:10.1023/b:cepr.0000012388.85901.1c · Cited by 15
Jones, N. R., Smith, M. C., Yang, Y., Hobbs, R. F., & Taylor, C. J. (2025) · The Lancet Healthy Longevity · doi:10.1016/j.lanhl.2025.100734 · Cited by 14
“6 An analysis of individuals in the Framingham Heart Study found that more than half of people with newly diagnosed heart failure had pre-existing atrial fibrillation, and more than a third of those with newly diagnosed atrial fibrillation had pre-existing heart failure.”
The effects of Papaver somniferum (Opium poppy) on health, its controversies and consensus evidence
Hedayati‐Moghadam, M., Moezi, S. A., Kazemi, T., Sami, A., Akram, M., Zainab, R., & Khazdair, M. R. (2021) · Toxin Reviews · doi:10.1080/15569543.2021.1958232 · Cited by 14
“(Wang et al. 2003) Human Injection Morphine Alleviated of ischemia.”
BackgroundShiga, T. (2022) · European Heart Journal Supplements · doi:10.1093/eurheartjsupp/suac023 · Cited by 14
Koniari, I. C., Gerakaris, A., Kounis, N. G., Velissaris, D., Rao, A., Ainslie, M., Adlan, A., Plotas, P., Ikonomidis, I., Mplani, V., et al. (2023) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd10070272 · Cited by 14
“In the Framingham Heart Study, among 1470 patients with AF or HF, 383 individuals (26%) suffered from both conditions [11].”
BackgroundAndo, M., Yanagisawa, S., Suzuki, H., Yoshida, Y., Kanzaki, Y., Morishima, I., Ishikawa, S., Kamikubo, Y., Okumura, S., Kato, H., et al. (2024) · JACC Asia · doi:10.1016/j.jacasi.2024.08.005 · Cited by 14
Early management of atrial fibrillation: from imaging to drugs to ablation
Shah, A. J., Liu, X., Jadidi, A., & Haı̈ssaguerre, M. (2010) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2010.49 · Cited by 14
Ceelen, F., Hunter, R. J., Boubertakh, R., Sommer, W. H., Armbruster, M., SCHILLING, R. J., & Petersen, S. E. (2013) · International journal of cardiac imaging · doi:10.1007/s10554-013-0287-6 · Cited by 14
Qin, D., Leef, G. C., Alam, M. B., Rattan, R., Munir, M. B., Patel, D. R., Khattak, F. H., Vaghasia, N., ADELSTEIN, E. C., Jain, S. K., et al. (2015) · Journal of the American Heart Association · doi:10.1161/jaha.115.001793 · Cited by 15
Device Therapy for Rate Control: Pacing, Resynchronisation and AV Node Ablation
Lau, D. H., Thiyagarajah, A., Willems, S., Rostock, T., Linz, D., Stiles, M. K., Kaye, D. M., Kalman, J. M., & Sanders, P. (2017) · Heart Lung and Circulation · doi:10.1016/j.hlc.2017.05.124 · Cited by 14
Jarman, J. W. E., Hunter, T. D., Hussain, W., March, J. L., Wong, T., & Markides, V. (2017) · Pragmatic and Observational Research · doi:10.2147/por.s134777 · Cited by 14
“Atrial fibrillation (AF) is a powerful independent risk factor for death, 1 ischemic stroke, 2 heart failure, 3 and reduced quality of life.”
Chan, C., Lin, Y., Chen, Y., Lu, Y., Chen, S., & Chen, Y. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20133224 · Cited by 15
“Similarly, 24% of patients with HF had a concurrent diagnosis of AF [4].”
BackgroundAtrial fibrillation: a leading cause of heart failure-related hospitalizations; a dual epidemic.
Ahmed, A., Ullah, W., Hussain, I., Roomi, S., Sattar, Y., Ahmed, F., Saeed, R., & Ashfaq, A. A. (2019) · Europe PMC (PubMed Central) · Cited by 14
Refocusing on the Primary Prevention of Heart Failure
Jafari, L., Suen, R. M., & Khan, S. S. (2020) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-020-00811-3 · Cited by 15
Effects of Atrial Fibrillation on Heart Failure Outcomes and NT-proBNP Levels in the GUIDE-IT Trial
Chouairi, F. K., Pacor, J., Miller, P. E., Fuery, M. A., Caraballo, C., Sen, S., Leifer, E., Felker, G. M., Fiuzat, M., O’Connor, C. M., et al. (2021) · Mayo Clinic Proceedings Innovations Quality & Outcomes · doi:10.1016/j.mayocpiqo.2021.02.005 · Cited by 14
Higgins, A. Y., Annapureddy, A., Wang, Y., Minges, K. E., Bellumkonda, L., Lampert, R. J., Rosenfeld, L. E., Jacoby, D. L., Curtis, J. P., Miller, E. J., et al. (2021) · American Heart Journal · doi:10.1016/j.ahj.2021.12.011 · Cited by 14
Zhao, D., Jiao, H., Zhong, X., Wang, W., & Li, L. (2022) · Medicine · doi:10.1097/md.0000000000031581 · Cited by 14
“Atrial fibrillation (AF), the most common arrhythmia in the clinic, significantly affects morbidity and mortality as a risk factor for worsening stroke, heart failure, and cardiovascular disease.[1,2] As of 2010, AF affects more than 33.”
BackgroundThe Use of Artificial Intelligence to Predict the Development of Atrial Fibrillation
Pipilas, D. C., Friedman, S. F., & Khurshid, S. S. (2023) · Current Cardiology Reports · doi:10.1007/s11886-023-01859-w · Cited by 13
“Since AF can be asymptomatic, individuals may present with stroke or heart failure as the first manifestation [8–10].”
BackgroundUtilizing human induced pluripotent stem cells to study atrial arrhythmias in the short QT syndrome
Shiti, A., Arbil, G., Shaheen, N., Huber, I., Setter, N., & Gepstein, L. (2023) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2023.08.003 · Cited by 16
Preoperative Arrhythmias Such as Atrial Fibrillation: Cardiovascular Surgery Risk Factor
Anghel, D., Anghel, R., Corciova, F. C., Enache, M., & Tinică, G. (2014) · BioMed Research International · doi:10.1155/2014/584918 · Cited by 14
“Some studies reveal a higher hospital mortality rate, whereas others do not [16, 18, 19].”
BackgroundAbidi, S. (2010) · Library and Archives Canada (Government of Canada) · Cited by 14
Gamst, J., Christiansen, C. F., Rasmussen, B. S., Rasmussen, L. H., & Thomsen, R. W. (2015) · Critical Care · doi:10.1186/s13054-015-1007-5 · Cited by 14
“In the general population, AF has been associated with substantially increased risk of mortality, stroke, and heart failure [6–8].”
BackgroundInterleukin‐37 elevation in patients with atrial fibrillation
Li, W., Li, S., Li, X., Jiang, S., & Han, B. (2016) · Clinical Cardiology · doi:10.1002/clc.22630 · Cited by 14
“In patients with existing HF, the development of AF doubles mortality; and in patients with existing AF, the development of HF triples mortality.(6) When AF and HF occur in combination, clinical outcomes are particularly poor.”
BackgroundCatheter ablation versus rate control in patients with atrial fibrillation and heart failure
Geng, J., Zhang, Y., Wang, Y., Cao, L., Song, J., Wang, B., Song, W., Ju, L., & Xu, W. (2017) · Medicine · doi:10.1097/md.0000000000009179 · Cited by 15
Zaen, J. V., Chételat, O., Lemay, M., Calvo, E. M., & Delgado-Gonzalo, R. (2019) · International Joint Conference on Biomedical Engineering Systems and Technologies (BIOSTEC) · doi:10.5220/0007347900330041 · Cited by 15
“It is also associated with a 3-fold risk of heart failure (Wang et al., 2003).”
BackgroundPiccini, J. P., Dufton, C., Carroll, I. A., Healey, J. S., Abraham, W. T., Khaykin, Y., Aleong, R. G., Krueger, S. K., Sauer, W. H., Wilton, S. B., et al. (2021) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.120.009591 · Cited by 14
Asbach, S., Olschewski, M., FABER, T. S., Zehender, M., Bode, C., & Brunner, M. (2008) · EP Europace · doi:10.1093/europace/eun014 · Cited by 14
Dehydroepiandrosterone sulfate levels and risk of atrial fibrillation: The Rotterdam Study
Krijthe, B. P., de Jong, F. H., Albert Hofman, D., Franco, O. H., Witteman, J. C. M., Stricker, B. H. C., & Heeringa, J. (2012) · European Journal of Preventive Cardiology · doi:10.1177/2047487312467903 · Cited by 15
Meyre, P. B., Aeschbacher, S., Blum, S., Reichlin, T., Haller, M. L., Rodondi, N., Müller, A. S., Bernheim, A., Beer, J. H., Moschovitis, G., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-62218-7 · Cited by 15
“Findingsfromprospective cohort studies suggest that AF is associated with an approximately 5-fold increased risk of stroke, 2-fold increased risk of myocardial infarction and death 1 – 3 , and at least a 3-fold increased risk of heart failure 1,4 .”
Incidence and risk factors for atrial fibrillation in patients with newly diagnosed heart failure
Martín‐Pérez, M., Ruigómez, A., Michel, A., & Rodríguez, L. A. G. (2016) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0000000000000403 · Cited by 13
Baher, A. A., & MARROUCHE, N. F. (2018) · Arrhythmia & Electrophysiology Review · doi:10.15420/aer.2018.17.2 · Cited by 13
Social and environmental risks as contributors to the clinical course of heart failure
Narita, K., & Amiya, E. (2021) · Heart Failure Reviews · doi:10.1007/s10741-021-10116-7 · Cited by 15
Genetics and Pharmacogenetics of Atrial Fibrillation
Owais, A., Barney, M., Ly, O. T., Brown, G. E., Chen, H., Sridhar, A., Pavel, M. A., Khetani, S. R., & Darbar, D. (2024) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2023.12.006 · Cited by 15
van Vliet, M., Aalberts, J. J. J., Hamelinck, C., Hauer, A. D., Hoftijzer, D., Monnink, S. H. J., Schipper, J., Constandse, J. C., Peters, N. S., Lip, G. Y. H., et al. (2025) · npj Digital Medicine · doi:10.1038/s41746-025-01555-9 · Cited by 13
Telemonitoring with an implantable loop recorder in outpatient heart failure care
Kort, R. S. S., Tuininga, Y. S., Bosker, H. A., Janssen, M., & Tukkie, R. (2018) · Netherlands Heart Journal · doi:10.1007/s12471-018-1198-x · Cited by 13
Hayashi, H., Abe, Y., Morita, Y., Yamaji, Y., Nakane, E., Haruna, Y., Haruna, T., & Inoko, M. (2018) · Journal of Cardiology · doi:10.1016/j.jjcc.2018.12.011 · Cited by 13
Tsuji, A., Masuda, M., Asai, M., Iida, O., Okamoto, S., Ishihara, T., Nanto, K., Kanda, T., Tsujimura, T., Matsuda, Y., et al. (2020) · Circulation Journal · doi:10.1253/circj.cj-20-0191 · Cited by 13
“Third, AF recurrence after discharge was quantified on the basis of intermittent short-time ECG and the patients’ symptom-triggered ECG, giving rise to the possibility that asymptomatic episodes of AF might have been without any fatal complications; (2) the composite endpoint of death and HF hospitalization during the…”
MethodHeart rate and adverse outcomes in patients with prevalent atrial fibrillation
Moschovitis, G., Johnson, L., Blum, S., Aeschbacher, S., Perna, M. L. D., Pagnamenta, A., Melchiorre, P. A. M., Benz, A. P., Kobza, R., Valentino, M. D., et al. (2021) · Open Heart · doi:10.1136/openhrt-2021-001606 · Cited by 13
Novel Predictor for New-Onset Atrial High-Rate Episode in Patients With a Dual-Chamber Pacemaker
Nishinarita, R., Niwano, S., Oikawa, J., Saito, D., Sato, T., Matsuura, G., Arakawa, Y., Kobayashi, S., Shirakawa, Y., Horiguchi, A., et al. (2021) · Circulation Reports · doi:10.1253/circrep.cr-21-0096 · Cited by 13
Munir, M. B., Khan, M. Z., Darden, D. J., Asad, Z. U. A., Osman, M., Singh, G. D., Srivatsa, U. N., Han, F. T., Reeves, R. R., & Hsu, J. C. (2022) · EP Europace · doi:10.1093/europace/euac043 · Cited by 13
Wybraniec, M. T., Mizia‐Szubryt, M., Cichoń, M., Wrona‐Kolasa, K., Kapłon‐Cieślicka, A., Gawalko, M. M., Budnik, M., Uziębło‐Życzkowska, B., Krzesiński, P., Starzyk, K., et al. (2022) · ESC Heart Failure · doi:10.1002/ehf2.14105 · Cited by 13
Jannou, V., Timsit, S., Nowak, E., Rouhart, F., Goas, P., Merrien, F.-M., Viakhireva-Dovganyuk, I., Tirel-Badets, A., & Gentric, A. (2015) · BMC Geriatrics · doi:10.1186/s12877-015-0067-3 · Cited by 13
“AF is associated with increased risks of: mortality [3], heart failure [4], dementia [5] and systemic embolism, with a 5-fold increase in risk of stroke [6].”
BackgroundDini, F. L., Gabutti, A., Passino, C., Fontanive, P., Emdin, M., & Tommasi, S. M. D. (2009) · International Journal of Cardiology · doi:10.1016/j.ijcard.2008.11.108 · Cited by 13
The Role of Continuous Monitoring in Atrial Fibrillation Management
Camm, A. J. (2011) · Arrhythmia & Electrophysiology Review · doi:10.15420/aer.2011.3.1.48 · Cited by 14
Non-vitamin K antagonist oral anticoagulants and heart failure
Isnard, R., Bauer, F., Solal, A. C., Damy, T., Donal, E., Galinier, M., Hagège, A. A., Patrick Jourdain, M., Leclercq, C., Sabatier, R., et al. (2016) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2016.08.001 · Cited by 13
Yoshihisa, A., Sato, Y., Sato, T., Suzuki, S., Oikawa, M., & Takeishi, Y. (2018) · BMC Cardiovascular Disorders · doi:10.1186/s12872-018-0746-z · Cited by 13
Risk factors for heart failure hospitalizations among patients with atrial fibrillation
Eggimann, L., Blum, S., Aeschbacher, S., Reusser, A., Ammann, P., Erné, P., Moschovitis, G., Valentino, M. D., Shah, D. C., Schläpfer, J., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0191736 · Cited by 13
Nakajima, I., Noda, T., Kanzaski, H., Kamakura, T., Wada, M., Ishibashi, K., Inoue, Y. Y., Miyamoto, K., Okamura, H., Nagase, S., et al. (2018) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2018.06.010 · Cited by 13
“7) Inappropriate shock 3 (3) 16 (24) 9.”
Catheter Ablation of Atrial Fibrillation in Patients With Heart Failure
Aldaas, O. M., Malladi, C., & Hsu, J. C. (2018) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2018.09.013 · Cited by 13
Xu, H.-X., Zhu, Y.-M., Hua, Y., Huang, Y., & Lu, Q. (2019) · Acta cardiologica. Supplementum · doi:10.1080/00015385.2019.1610834 · Cited by 13
Impact of Left Atrial Sphericity Index on the Outcome of Catheter Ablation for Atrial Fibrillation
Shi, J., Xu, S., Chen, L., Wu, B., Yang, K., Chen, S., Zhou, D., Zhang, B., Xuan, T., & Hu, X. (2021) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-020-10093-6 · Cited by 13
Prediction of Congestive Heart Failure in Patients with Non Valvular Atrial Fibrillation
Imai, K., Okura, H., Tamada, T., Fukuhara, K., Koyama, T., Kume, T., Hayashida, A., Kawamoto, T., Neishi, Y., & Yoshida, K. (2013) · Internal Medicine · doi:10.2169/internalmedicine.53.0962 · Cited by 13
McMurray, J. J. V., & Pfeffer, M. A. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.09.070 · Cited by 13
Shen, W., Zhang, Y., Qian, W., Li, C., Wang, C., Li, W., Li, J., Chen, J., Wei, Y., Liu, Y., et al. (2025) · EP Europace · doi:10.1093/europace/euaf175 · Cited by 12
Noubiap, J. J., Nyaga, U. F., Middeldorp, M. E., Fitzgerald, J. L., Ariyaratnam, J., Thomas, G., & Sanders, P. (2022) · Respiratory Medicine · doi:10.1016/j.rmed.2022.106862 · Cited by 12
The growing burden of atrial fibrillation and its consequences
Wu, J., & Nadarajah, R. (2024) · BMJ · doi:10.1136/bmj.q826 · Cited by 12
Hougham, G. W., Ham, S. A., Ruhnke, G. W., Schulwolf, E., Auerbach, A. D., Schnipper, J. L., Kaboli, P. J., Wetterneck, T. B., Gonzalez, D. M., Arora, V. M., et al. (2013) · Journal of General Internal Medicine · doi:10.1007/s11606-013-2626-7 · Cited by 12
Bonnemeier, H., BOSCH, R. F., Kohlhaußen, A., Rosin, L., Willich, S. N., Pittrow, D. B., Kirch, W., & for the MOVE Study Group (2011) · Current Medical Research and Opinion · doi:10.1185/03007995.2011.563286 · Cited by 12
Kaneko, H., Neuß, M., Schau, T., Weissenborn, J., & Butter, C. (2016) · Heart and Vessels · doi:10.1007/s00380-016-0822-1 · Cited by 12
Xiao, Y.-Q., Cai, X., Atkinson, A. J., Logantha, S. J. R. J., Boyett, M. R., & Dobrzynski, H. (2016) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2016.3766 · Cited by 12
“In addition, AF carries a 3‑fold increased risk of heart failure (4,5), and a 2‑fold increased risk of both dementia (6) and mortality (3,7).”
Ohsawa, M., Okamura, T., Tanno, K., Ogasawara, K., Itai, K., Yonekura, Y., Konishi, K., Omama, S., Miyamatsu, N., Turin, T. C., et al. (2017) · Journal of Epidemiology · doi:10.1016/j.je.2016.08.012 · Cited by 12
Intra-thoracic Impedance and the Onset of Atrial and Ventricular Tachyarrhythmias: A Meta-analysis
Abubakar, H., Osman, M., Akintoye, E. O., Subahi, A., Osman, K., & Abidov, A. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.12.092 · Cited by 12
Identifying Atrial Fibrillation Mechanisms for Personalized Medicine
Deb, B., Ganesan, P., Feng, R., & Narayan, S. M. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10235679 · Cited by 12
Implantable defibrillator-detected heart failure status predicts atrial fibrillation occurrence
Bertini, M., Vitali, F., Santini, L., Tavoletta, V., Giano, A., Savarese, G., Russo, A. D., Santobuono, V. E., Mattera, A., Lavalle, C., et al. (2022) · Heart Rhythm · doi:10.1016/j.hrthm.2022.01.020 · Cited by 12
Deshpande, R., Al‐Khadra, Y., SINGANALLUR, P. M., Botchway, A., & Labedi, M. R. (2022) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-022-01365-z · Cited by 13
Pay, L., Yumurtaş, A. Ç., Tezen, O., Çetin, T., Eren, S., Çinier, G., Hayıroğlu, M. İ., & Tekkeşin, A. İ. (2023) · Korean Circulation Journal · doi:10.4070/kcj.2022.0353 · Cited by 12
INVESTIGATION OF MICRO SPIRAL WAVES AT CELLULAR LEVEL USING A MICROELECTRODE ARRAYS TECHNOLOGY
Jacquir, S., Binczak, S., Xu, B., Laurent, G., Vandroux, D., Athias, P., & Bilbault, J. (2011) · International Journal of Bifurcation and Chaos · doi:10.1142/s0218127411028374 · Cited by 12
“Many studies of cardiac arrhythmia focused on the spatiotemporal propagation of the electrical waves throughout the myocardium [Wang et al, 2003; Winfree, 1994; Agladze et al, 1994; Gray et al, 1995, 1997; Everett et al, 2006].”
BackgroundSR calcium handling dysfunction, stress-response signaling pathways, and atrial fibrillation
Ai, X. (2015) · Frontiers in Physiology · doi:10.3389/fphys.2015.00046 · Cited by 12
Gould, P. A., Esler, M., & Kaye, D. M. (2008) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2008.01152.x · Cited by 12
Impact of aortic stiff ness on the frequency of paroxysmal atrial fi brillation recurrences
Kızılırmak, F., Güler, G. B., Güler, E., Güneş, H. M., Demır, G. G., Omaygenç, M. O., Çakal, B., Olgun, F. E., Köklü, E., & Kılıçaslan, F. (2015) · Acta cardiologica. Supplementum · doi:10.1080/ac.70.4.3094650 · Cited by 12
Association of cardiac cachexia and atrial fibrillation in heart failure patients
Arámbula-Garza, E., Castillo‐Martínez, L., González‐Islas, D., Orea‐Tejeda, A., Santellano-Juárez, B., Keirns-Davies, C., Peláez-Hernández, V., Sánchez‐Santillán, R., Pineda-Juárez, J. A., Cintora-Martínez, C., et al. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.08.318 · Cited by 12
Lenzi, J., Avaldi, V. M., Hernandez‐Boussard, T., Descovich, C., Castaldini, I., Urbinati, S., Pasquale, G. D., Rucci, P., & Fantini, M. P. (2016) · BMC Health Services Research · doi:10.1186/s12913-016-1731-9 · Cited by 12
“Atrial fibrillation is a common morbidity in HF and both conditions are associated with poor outcomes [35] and cardiovascular mortality [25].”
BackgroundSuzuki, S. S., Otsuka, T., Sagara, K., Semba, H., Kano, H., Matsuno, S., Takai, H., Kato, Y., Uejima, T., Oikawa, Y., et al. (2017) · International Heart Journal · doi:10.1536/ihj.16-228 · Cited by 12
Daneshvar, M., Desai, N. K., Andriulli, J. A., Ortman, M. L., Eno, E., Hunter, K. M., & Russo, A. M. (2017) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2017.11.014 · Cited by 12
Feasibility study on stereotactic radiotherapy for total pulmonary vein isolation in a canine model
Chang, J. H., Cha, M., Seo, J., Kim, H. J., Park, S. Y., Kim, B. H., Lee, E., Kim, M.-K., Yoon, H.-S., & Oh, S. (2021) · Scientific Reports · doi:10.1038/s41598-021-91660-y · Cited by 12
Refined atrial fibrillation screening and cost-effectiveness in the German population
Schnabel, R. B., Wallenhorst, C., Engler, D., Blankenberg, S., Pfeiffer, N., Sprünker, N.-A., Buettner, M., Michal, M., Lackner, K. J., Münzel, T. F., et al. (2021) · Heart · doi:10.1136/heartjnl-2020-318882 · Cited by 12
Zheng, C., Han, L., Tian, J., Li, J., He, H., Han, G., Wang, K., Yang, H., Yan, J., Meng, B., et al. (2021) · ESC Heart Failure · doi:10.1002/ehf2.13708 · Cited by 12
“In patients with HF, the development of AF doubled the mortality, while in AF patients, it tripled the mortality.(26,27) Although the ischaemic cluster had fewer comorbidities, 77.”
BackgroundNoubiap, J. J., Thomas, G., Nyaga, U. F., Fitzgerald, J. L., Gallagher, C., Middeldorp, M. E., & Sanders, P. (2022) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.15421 · Cited by 12
Miyazaki, S., Miyauchi, K., Hayashi, H., Yamashiro, K., Tanaka, R., Nishizaki, Y., Nojiri, S., Suwa, S., Sumiyoshi, M., Nakazato, Y., et al. (2022) · Journal of Cardiology · doi:10.1016/j.jjcc.2022.03.006 · Cited by 12
Electrocardiographic Assessment of Incident Atrial Fibrillation in Hemodialysis Patients
Nishi, K., Fujimoto, S., Hisanaga, S., Ogawa, O., & Kitamura, K. (2012) · Therapeutic Apheresis and Dialysis · doi:10.1111/j.1744-9987.2012.01137.x · Cited by 12
“with increases in stroke, mortality, and fatal heart failure (3,4).”
BackgroundIto, H., & Dajani, K. A. (2009) · Current Cardiology Reviews · doi:10.2174/157340309787048121 · Cited by 12
“In addition, AF is associated with poor exercise capacity, an increased risk of heart failure and all-cause mortality although its causality remains unclear [4,5].”
BackgroundManagement of Atrial Fibrillation
Zamani, P. L., & Verdino, R. J. (2014) · Journal of Intensive Care Medicine · doi:10.1177/0885066614534603 · Cited by 12
“Several studies suggest that the presence of atrial fibrillation is associated with a worse prognosis in patients with heart failure.(69,70) Furthermore, the additional contribution of atrial contraction to LV filling may be more substantial in patients with heart failure.”
BackgroundPunjani, S., Wu, W., Cohen, S. B., Sharma, S. C., & Choudhary, G. (2011) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2011.01.008 · Cited by 12
Chen, S.-Y., Crivera, C., Stokes, M., Boulanger, L., & Schein, J. (2014) · BMC Health Services Research · doi:10.1186/1472-6963-14-80 · Cited by 11
“; licensee BioMed Central L Commons Attribution License (http://creativec reproduction in any medium, provided the or the development of AF appears to increase the risk of mortality from HF and vice versa [3-5].”
Raatikainen, M. J. P., Penttilä, T., Korhonen, P. A., Mehtälä, J., Lassila, R., & Lehto, M. (2018) · European Heart Journal - Cardiovascular Pharmacotherapy · doi:10.1093/ehjcvp/pvy009 · Cited by 12
Zhu, K., Hung, J., Divitini, M., Murray, K., Lim, E. M., John, A. S., Walsh, J. P., & Knuiman, M. W. (2018) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2018.05.003 · Cited by 12
Atrial fibrillation and cardiac resynchronization therapy: the MASCOT study
Padeletti, L., Musilli, N., PORCIANI, M., Colella, A., Biase, L. D., Ricciardi, G., Pieragnoli, P., Michelucci, A., & Gensini, G. F. (2004) · EP Europace · doi:10.1016/j.eupc.2004.07.007 · Cited by 12
Raviele, A. (2006) · Springer eBooks · doi:10.1007/88-470-0371-7 · Cited by 12
Guha, A., Dunleavy, M. P., Hayes, S. A., Afzal, M. R., Daoud, E. G., Raman, S. V., & Harfi, T. T. (2020) · International Journal of Cardiology · doi:10.1016/j.ijcard.2020.06.035 · Cited by 11
Huang, T., Nairn, D., Chen, J., Mueller-Edenborn, B., Pilia, N., Mayer, L., Eichenlaub, M., Weidmann, Z. M., Allgeier, J., Trenk, D., et al. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.1101152 · Cited by 11
Pope, M. K., Hall, T. S., Virdone, S., Atar, D., Camm, A. J., Pieper, K. S., Janský, P., Haas, S. K., Goto, S., Панченко, Е. П., et al. (2023) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2023.101302 · Cited by 11
“Atrial fibrillation (AF) is associated with major health challenges, such as an increased risk of stroke [1,2], heart failure [3,4], hospital-isation [5,6], cognitive impairment and dementia [7,8], and mortality [1,9,10].”
BackgroundHuang, J., Chan, Y., Tse, Y., Yu, S.-Y., Li, H., Chen, C., Zhao, C., Liu, M., Wu, M., Ren, Q. W., et al. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.123.032378 · Cited by 12
“32 Our study, using a large contemporary population with AF, corroborates with previous studies to highlight the profoundly high HF and related mortality risk in patients with AF.”
Ninni, S., Algalarrondo, V., Brette, F., Lemesle, G., & Fauconnier, J. (2024) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2024.02.001 · Cited by 13
Qing, Y. A. N., LIANG, J.-Q., Yi-De, Y. U. A. N., Yuan, L. I., Jia-Li, F. A. N., Wen-Huan, W. U., Pan, X. U., & Xue, J. (2024) · 老年心脏病学杂志:英文版 · doi:10.26599/1671-5411.2024.02.005 · Cited by 11
GWAS advancements to investigate disease associations and biological mechanisms
Omidiran, O., Patel, A., Usman, S., Mhatre, I., Abdelhalim, H., DeGroat, W., Narayanan, R., Singh, K., Mendhe, D., & Ahmed, Z. (2024) · Clinical and Translational Discovery · doi:10.1002/ctd2.296 · Cited by 14
Multidisciplinary Approach in Atrial Fibrillation: As Good as Gold
Lucà, F., Abrignani, M. G., Oliva, F. G., Canale, M. L., Parrini, I., Murrone, A., Rao, C. M., Nesti, M., Cornara, S., Matteo, I. D., et al. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13164621 · Cited by 17
“Moreover, these conditions have a negative prognostic impact on each other [136–139], raising challenges in therapeutic management.”
BackgroundWilber, D. J., Pappone, C., Neuzil, P., De Paola, A., Marchlinski, F., Natale, A., Macle, L., Daoud, E. G., Calkins, H., Hall, B., et al. (2010) · JAMA · doi:10.1001/jama.2009.2029 · Cited by 1,170
Metadata
- Authors
- Wang, T. J., Larson, M. G., Levy, D., Vasan, R. S., Leip, E. P., Wolf, P. A., D’Agostino, R. B., Murabito, J. M., Kannel, W. B., & Benjamin, E. J.
- Affiliations
- Boston University (US)
- ORCID
- Venue
- Circulation
- Published
- 2003-06-17
- Volume
- 107
- Issue
- 23
- Pages
- 2920-2925
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W1998083759
- Cited by
- 1,970
- References
- 28
- Citations by year
- 2026: 49 · 2025: 65 · 2024: 114 · 2023: 93 · 2022: 117 · 2021: 137 · 2020: 109 · 2019: 103 · 2018: 120 · 2017: 107 · 2016: 111 · 2015: 115 · 2014: 112 · 2013: 101 · 2012: 84
- FWCI
- 27.01
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Circulation (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (n01hc25195-41-0-1)
- National Heart, Lung, and Blood Institute (K24-HL-04334-01A1, N01‐HC25195, K24HL004334)
- National Institute of Neurological Disorders and Stroke (5-RO1-NS-17950, R01NS017950)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Health and Mental Health
- Keywords
- atrial fibrillation, congestive heart failure, mortality, comorbidities, prognosis, Framingham Heart Study
- MeSH terms
- Aged, Atrial Fibrillation, Female, Follow-Up Studies, Heart Failure, Humans, Male, Massachusetts, Middle Aged, Prognosis, Risk Factors, Cohort Studies, Comorbidity, Incidence, Multivariate Analysis, Proportional Hazards Models, Survival Analysis, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review